The U.S. Department of Health and Human Services, meanwhile, announced Thursday it is committing $500 million for clinical trials evaluating experimental vaccines against COVID-19.
The bulk of the money is going to California-based Vaxart, which is developing a pill vaccine.
https://www.theepochtimes.com/us/fda-changes-course-advises-updated-covid-19-vaccines-target-kp-2-strain-5668714?utm
The bulk of the money is going to California-based Vaxart, which is developing a pill vaccine.
https://www.theepochtimes.com/us/fda-changes-course-advises-updated-covid-19-vaccines-target-kp-2-strain-5668714?utm
The U.S. Department of Health and Human Services, meanwhile, announced Thursday it is committing $500 million for clinical trials evaluating experimental vaccines against COVID-19.
The bulk of the money is going to California-based Vaxart, which is developing a pill vaccine.
https://www.theepochtimes.com/us/fda-changes-course-advises-updated-covid-19-vaccines-target-kp-2-strain-5668714?utm
0 Comments
1 Shares
261 Views
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek